(19)
(11) EP 1 652 517 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.04.2012 Bulletin 2012/15

(45) Mention of the grant of the patent:
22.02.2012 Bulletin 2012/08

(21) Application number: 04736983.0

(22) Date of filing: 17.06.2004
(51) International Patent Classification (IPC): 
A61K 9/51(2006.01)
 C08B 37/08(2006.01)
(86) International application number:
PCT/ES2004/000284
(87) International publication number:
WO 2004/112758 (29.12.2004 Gazette 2004/53)

(54)

HYALURONIC ACID NANOPARTICLES

HYALURONSÄURE-NANOPARTIKEL

NANOPARTICULES D'ACIDE HYALURONIQUE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 20.06.2003 ES 200301456

(43) Date of publication of application:
03.05.2006 Bulletin 2006/18

(73) Proprietor: ADVANCELL ADVANCED IN VITRO CELL TECHNOLOGIES, S.A
08028 Barcelona (ES)

(72) Inventors:
  • ALONSO FERNANDEZ, Maria, José
    E-15782 Santiago de Compostela (ES)
  • DE LA FUENTE FREIRE, Maria
    E-15782 Santiago de Compostela (ES)
  • SEIJO REY, Maria, Begona
    E-15782 Santiago de Compostela (ES)

(74) Representative: ABG Patentes, S.L. 
Avenida de Burgos 16D Edificio Euromor
28036 Madrid
28036 Madrid (ES)


(56) References cited: : 
WO-A1-2004/009060
ES-A1- 2 114 502
 ES-A1- 2 098 188
FR-A1- 2 642 329
   
  • LIM S.T. ET AL.: 'Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan' J. CONTROL. REL. vol. 66, no. 2-3, May 2000, pages 281 - 292, XP002291345
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).